• Sevuparin Fails to Show Clinically Meaningful Improvements in Managing VOCs, Phase 2 Study Shows
  • GBT Awards $200K in ACCEL Grants to Improve SCD Healthcare Delivery
  • Sickle Cell Advocate Howard Woolley Wins Prestigious Award for Working to Improve Patient Care
  • SCDAA Plans June 22 ‘Walk With the Stars’ Fundraiser in Baltimore
  • FDA Grants Fast Track Status to Imara’s IMR-687 Candidate Therapy for Sickle Cell Disease
  • Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries
  • Novartis’ STEP Program Funding Projects Supporting Sickle Cell Community
  • Participants Sought for Trial Evaluating Olinciguat for Sickle Cell Disease
  • Stakeholders Call for Improved Care for SCD Patients in California
  • Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns
  • SCD Experts Call for Routine Screening Among Migrants
  • Cognitive Function May Be Affected in Adults with Sickle Cell Disease, Study Suggests